Traditional Chinese medicine formulas for irritable bowel syndrome: From ancient wisdoms to scientific understandings

American Journal of Chinese Medicine

Volumn 43, Issue 1, 2015, Pages 1-23

  Xiao, Hai Tao ^a   Zhong, Linda ^a   Tsang, Siu Wai ^a   Lin, Ze Si ^a   Bian, Zhao Xiang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Action Mechanisms; Efficacy and Safety; Irritable Bowel Syndrome; Multi targeting Therapy; Traditional Chinese Medicine Formulas

Indexed keywords

CHANG JI LING; DEANXIT; HERBACEOUS AGENT; HORMONE; LOPERAMIDE; MIYARISAM; NEUROTRANSMITTER; PINAVERIUM; PINAVERIUM BROMIDE; PLACEBO; SHEN LING BAI ZHU; SHU GAN JIE YU; SOMATOSTATIN; SUBSTANCE P; TIAO HE GAN PI HE XIN; TONG XIE NING; TONG XIE YAO FANG; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CHOLECYSTOKININ; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SEROTONIN;

ABDOMINAL PAIN; ALLOPATHY; ARTICLE; CHINESE MEDICINE; COLON MOTILITY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HEADACHE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; NAUSEA; NONHUMAN; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SMOOTH MUSCLE; THYROIDITIS; VOMITING; DRUG EFFECTS; GASTROINTESTINAL MOTILITY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTESTINE; IRRITABLE BOWEL SYNDROME; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

CHOLECYSTOKININ; DRUGS, CHINESE HERBAL; GASTROINTESTINAL MOTILITY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTESTINES; IRRITABLE BOWEL SYNDROME; MEDICINE, CHINESE TRADITIONAL; MUSCLE, SMOOTH; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PITUITARY-ADRENAL SYSTEM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN; SIGNAL TRANSDUCTION; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84928476817     PISSN: 0192415X     EISSN: 17936853     Source Type: Journal    
DOI: 10.1142/S0192415X15500019     Document Type: Article

References (80)

1. Akiho, H., E. Ihara and K. Nakamura. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J. Gastrointest. Pathophysiol. 1: 97-105, 2010.
2. Bensoussan, A., N.J. Talley, M. Hing, R. Menzies, A. Guo and M. Ngu. Treatment of irritable bowel syndrome with Chinese herbal medicine: A randomized controlled trial. JAMA 280: 1585-1589, 1998.
3. Bravo, J.A., T.G. Dinan and J.F. Cryan. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int. J. Neuropsychopharmacol. 14: 666-683, 2011.
4. Camilleri, M. and V. Andresen. Current and novel therapeutic options for irritable bowel syndrome management. Dig. Liver Dis. 41: 854-862, 2009.
5. Chang, J.Y. and N.J. Talley. Current and emerging therapies in irritable bowel syndrome: From pathophysiology to treatment. Trends Pharmacol. Sci. 31: 326-334, 2010.
6. Chen, F.S., H.J. Suo and H. Fan. Efficacy of Shuanjieyu Decoction in the treatment of patients with diarrhea-predominant irritable bowel syndrome: An analysis of 30 cases. World Chin. J. Digestol. 18: 2715-2718, 2010.
7. Chen, Z.Y., M.X. Yan and B.K. Xiang. The effects of Tiaogan Shipi Fang on gastrointestinal hormones of hepatic stagnation and spleen deficiency type IBS patients. J. Tradit. Chin. Med. 44: 928, 2003.
8. Gerkens, A. Irritable bowel syndrome: Diet and complementary medicine therapies? Rev. Med. Brux 33: 430-435, 2012.
9. Gershon, M.D. and J. Tack. The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology 132: 397-414, 2007.
10. Guan, Q.C., B. Lv, L.N. Heng, S.Z. Lu and Z.Y. Guo. Effect of Changyanning Tangjiang on the expression of corticotropin releasing factor in spinal cord and brain of rats with visceral hypersensitivity. World Chin. J. Digestol. 16: 2112-2118, 2008.
11. Guilarte, M., J. Santos, I. de Torres, C. Alonso, M. Vicario, L. Ramos, C. Martínez, F. Casellas, E. Saperas and J.R. Malagelada. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 56: 203-209, 2007.
12. Hu, R. and F. Tang. The effects of Weichang'an Pill on the serum VIP and electrolyte of IBS model rats. Shaanxi J. Tradit. Chin. Med. 31: 914-916, 2010.
13. Hu, X.G., X.Y. Wang, N. Song, J.R. Chang, F.S. Zhou and R.J. Wang. The effects and mechanisms of Kangtai capsule on visceral hypersensitivity rats. J. Chin. Med. Mater. 30: 1563-1567, 2007a.
14. Hu, X.G., S.W. Zhang and X. Xiang. Curative effects of prescription of soothing the liver, prescription of strengthening the spleen and prescription of soothing the liver and strengthening the spleen on IBS model rats and its mechanism. Henan Tradit. Chin. Med. 27: 23-24, 2007b.
15. Hu, X.Y., X.S. Qiu, X.G. Chen, W.P. Zhang, S.H. Xu, Z.Z. Chen and Y.R. Li. Effect of Tiaochang Huanji prescription on microecology in children with irritable bowel syndrome. J. Guangzhou Univ. Tradit. Chin. Med. 25: 63-67, 2008.
16. Hua, C.Y. Tongxie Yaofang's Add-subtract in treatment with D-IBS before examination randomized controlled clinical study. J. Pract. Tradit. Chin. Med. 27: 41-42, 2013.
17. Huang, S., S.N. Lin, L.M. Lei, H.F. Yuan, C. Tan and X.L. Zhang. Effect of water therapy with Anchang decoction through colon on IL-1? and IL-10 in patients with irritable bowel syndrome of diarrhea type. Mod. J. Integr. Tradit. Chin. West. Med. 19: 11-12, 2010.
18. Huang, S.G. and Y.T. Li. Randomized controlled trial of Chinese herbal compound recipe of Changjiling for diarrhea-predominant irritable bowel syndrome. J. Guangzhou Univ. Tradit. Chin. Med. 30: 152-156, 2013.
19. Jacob, R.A. and G. Sotoudeh. Vitamin C function and status in chronic disease. Nutr. Clin. Care 5: 66-74, 2002.
20. Jeong, S.I., Y.S. Kim, M.Y. Lee, J.K. Kang, S. Lee, B.K. Choi and K.Y. Jung. Regulation of contractile activity by magnolol in the rat isolated gastrointestinal tracts. Pharmacol. Res. 59: 183-188, 2009.
21. Kim, J.H., J.H. Lee, S.M. Jeong, B.H. Lee, I.S. Yoon, S.H. Choi and S.Y. Nah. Effect of Ginseng saponins on a rat visceral hypersensitivity model. Biol. Pharm. Bull. 28: 2120-2124, 2005.
22. Lee, B.H., S.M. Jeong, J.H. Lee, D.H. Kim, J.H. Kim, J.I. Kim, H.C. Shin, S.M. Lee and S.Y. Nah. Differential effect of ginsenoside metabolites on the 5-HT3A receptor-mediated ion current in Xenopus oocytes. Mol. Cells 17: 51-56, 2004.
23. Leung, W.K., J.C. Wu, S.M. Liang, L.S. Chan, F.K. Chan, H. Xie, S.S. Fung, A.J. Hui, V.W. Wong, C.T. Che and J.J. Sung. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: A randomized placebo-controlled trial. Am. J. Gastroenterol. 101: 1574-1580, 2006.
24. Li, D.H., C.Y. Li, W.S. Li, Z.D. Zhou and Y.H. Zhang. The effect of Tongxieyaofang on vasoactive intestinal polypeptide in rats of irritable bowel syndrome. Lishizhen Med. Mater. Med. Res. 18: 2098-2099, 2007.
25. Li, H.G. and J.E. Yu. Effects of Zhengchangling on gastrointestinal hormone of rats irritable bowel syndrome with splenogastric deficiency. J. Henan Univ. (Medical Science) 21: 11-14, 2002.
26. Li, Q. and J.L. Jiang. Efficacy of Shenling Baizhu Granules in the treatment of diarrhea-predominant irritable bowel syndrome. Guiding J. Tradit. Chin. Med. Pharm. 19: 41-42, 2013.
27. Liang, Z.F., R.H. Chen, Y.S. Xu, Q.X. Chen and M.L. Dong. Tiaohe Ganpi Hexin decoction in treatment of irritable bowel syndrome with diarrhea: A randomized controlled trial. Zhong Xi Yi Jie He Xue Bao 7: 819-822, 2009.
28. Lin, Z.Q. and W.B. Zhou. The effects of Danhong injection on the serum IL-8 and TNF-? of IBS patients. Jilin Med. J. 31: 70-71, 2010.
29. Liu, J.P., M. Yang, Y.X. Liu, M. Wei and S. Grimsgaard. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst. Rev. CD004116, 2006.
30. Lu, W. Chinese herbal medicine for irritable bowel syndrome. JAMA 282: 1035-1037, 1999.
31. Ma, J. and J.Y. Pan. Effect of additional Tongxie Yaofang decoction on gastrointestinal hormone in patients with diarrhea-predominant IBS. Mod. J. Integr. Tradit. Chin. West. Med. 16: 2969-2971, 2007.
32. Ma, W., L.Z. Long, Z.P. Peng, J.X. Teng and J. Tan. Effect of Jiuxiang Zhixie tablet on plasma of vasoactive intestinal peptide, neuropeptide Y and 5-hydroxytryptamine of bowel mucosa in rats with diarrhea irritable bowel syndrome. J. Tradit. Chin. Med. Univ. Hunan 29: 29-32, 2009.
33. Maciocia, G. The Foundations of Chinese Medicine: A Comprehensive Text for Acupuncturists and Herbalists. Churchill Livingstone, Edinburgh, New York, 1989.
34. Martinez, V. and Y. Tache. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr. Pharm. Des. 12: 4071-4088, 2006.
35. Min, K.T., B.N. Koo, J.W. Kang, S.J. Bai, S.R. Ko and Z.H. Cho. Effect of Ginseng saponins on the recombinant serotonin type 3A receptor expressed in xenopus oocytes: Implication of possible application as an antiemetic. J. Altern. Complement. Med. 9: 505-510, 2003.
36. Mohammad-Zadeh, L.F., L. Moses and S.M. Gwaltney-Brant. Serotonin: A review. J. Vet. Pharmacol. Ther. 31: 187-199, 2008.
37. Munoz, M. and R. Covenas. NK-1 receptor antagonists: A new paradigm in pharmacological therapy. Curr. Med. Chem. 18: 1820-1831, 2011.
38. Ohman, L. and M. Simren. Pathogenesis of IBS: Role of inflammation, immunity and neuroimmune interactions. Nat. Rev. Gastroenterol. Hepatol. 7: 163-173, 2010.
39. Palsson, O.S., O. Morteau, E.M. Bozymski, J.T. Woosley, R.B. Sartor, M.J. Davies, D.A. Johnson, M.J. Turner and W.E. Whitehead. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig. Dis. Sci. 49: 1236-1243, 2004.
40. Pan, F., T. Zhang, Y.H. Zhang, J.J. Xu and F.M. Chen. Effect of Tongxie Yaofang Granule in treating diarrhea-predominate irritable bowel syndrome. Chin. J. Integr. Med. 15: 216-219, 2009.
41. Pan, X.Q. and J.Q. Xie. Inhibitive effects of "Shugan Decoction" on isolated colonic longitudinal smooth muscle strips contraction in rats. Shanghai J. Tradit. Chin. Med. 44: 106-108, 2010.
42. Pan, X.X. The effects of Shugan Decoction on CRH and NT in rats of diarrhea-predominant irritable bowel syndrome. Chin. J. Mod. Drug Appl. 4: 24-27, 2010.
43. Peng, S.L., H.Z. Huang, J.C. Lin and L.L. Liu. Clinical research of treatment of diarrhea-predominant irritable bowel syndrome with Qiwei Baizhu powder and Tongxie Yaofang. J. Liaoning Univ. TCM 15: 187-189, 2013.
44. Peng, W., J.Y. Pan, J. Ma and D.J. Zheng. Effects of Jiechangling decoction on the expressions of braingut petide in intestine and posterior horn of spinal cord in the rat model of irritable bowel syndrome. Mod. J. Integr. Tradit. Chin. West. Med. 18: 2632-2634, 2697, 2009.
45. Qin, H.Y., H.T. Xiao, F.P. Leung, Z.J. Yang, J.C. Wu, J.J. Sung, H.X. Xu, X.D. Tong and Z.X. Bian. JCM-16021, a Chinese herbal formula, attenuated visceral hyperalgesia in TNBS-induced postinflammatory irritable bowel syndrome through reducing colonic EC cell hyperplasia and serotonin availability in rats. Evid. Based Complement. Alternat. Med. 2012: 239638, 2012.
46. Ross, J. Zang Fu, the Organ Systems of Traditional Chinese Medicine: Functions, Interrelationships and Patterns of Disharmony in Theory and Practice. Churchill Livingstone, Edinburgh, New York, 1985.
47. Salonen, A., W.M. de Vos and A. Palva. Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives. Microbiology 156: 3205-3215, 2010.
48. Sanger, G.J. 5-Hydroxytryptamine and the gastrointestinal tract: Where next? Trends Pharmacol. Sci. 29: 465-471, 2008.
49. Shi, J., Y. Tong, J.G. Shen and H.X. Li. Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: A systematic review. World J. Gastroenterol. 14: 454-462, 2008a.
50. Shi, J.J. Experimental study of Tiao-Gan Jian-Pi method on irritable bowel syndrome in wrap restraint stress rats. Mod. J. Integr. Tradit. Chin. West. Med. 14: 722-723, 802, 2005.
51. Shi, J.J. Regulation of Ning Chang decoction on free radical of stressed IBS rats. Chin. Arch. Tradit. Chin. Med. 26: 323-325, 2008.
52. Shi, J.J., Y.Y. Dai and F.Y. Xu. Effect of Xiaoyao powder on the corticosterone level in serum of irritable bowel syndrome rat. Shandong J. Tradit. Chin. Med. 27: 46-49, 2008b.
53. Shi, J.J., F.Y. Xu, L.Y. Song, S.X. Mei, D.P. Tao and H.Y. Wang. Effect of Xiaoyansan on 5-hydroxytryptamine receptors in rats with irritable bowel syndrome. Zhejiang J. Integr. Tradit. Chin. West. Med. 22: 172-174, 2012.
54. Sun, X., G. Cai and W.J. Wang. Observation on intestinal flora in patients of irritable bowel syndrome after treatment of Chinese integrative medicine. J. Chin. Integr. Med. 9: 340-342, 2004.
55. Sung, J.J.Y., W.K. Leung, J.Y.L. Ching, L. Lao, G. Zhang, J.C.Y. Wu, S.M. Liang, H. Xie, Y.P. Ho, L.S. Chan, B. Berman and F.K.L. Chan. Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome. Aliment. Pharmacol. Ther. 20: 1205-1210, 2004.
56. Talme, T. and K.-G. Sundqvist. The effects of somatostatin on immune cells, functions and diseases. In: M. Levite (ed.), Nerve-Driven Immunity. Springer Vienna, 2012, pp. 203-225.
57. Tan, S., K. Tillisch, S.R. Bolus, T.I. Olivas, B.M. Spiegel, B. Naliboff, L. Chang and E.A. Mayer. Traditional Chinese medicine based subgrouping of irritable bowel syndrome patients. Am. J. Chin. Med. 33: 365-379, 2005.
58. Tang, H.M., D.T. Li, Y.H. Huang and Z.W. Qiu. Effect of Changji'an prescription on depressing the mast cells in rats with irritable bowel syndrome. Tradit. Chin. Drug Res. Clin. Pharmacol. 19: 464-466, 2008a.
59. Tang, H.M., Z.W. Qiu, D.T. Li, Z.S. Kuang and X. Yan. Mechanism research of Changji'an Fang intervention on SP and CGRP in model rats of diarrhea-irritable bowel syndrome. Pharm. Today 18: 1-4, 2008b.
60. Tjong, Y.W., S.P. Ip, L. Lao, J. Wu, H.H. Fong, J.J. Sung, B. Berman and C.T. Che. Role of neuronal nitric oxide synthase in colonic distension-induced hyperalgesia in distal colon of neonatal maternal separated male rats. Neurogastroenterol. Motil. 23: 666-e278, 2011.
61. van Bergeijk, J.D. and J.H. Wilson. Somatostatin in inflammatory bowel disease. Mediators Inflamm. 6: 303-309, 1997.
62. Varga, G., A. Bálint, B. Burghardt and M. D'Amato. Involvement of endogenous CCK and CCK1 receptors in colonic motor function. Br. J. Pharmacol. 141: 1275-1284, 2004.
63. Wang, F.L., C.H. Yang, W. Liu and L.J. Wang. Efficacy of Tongxie Yaofang in the treatment of diarrhea-predominant irritable bowel syndrome. J. Pract. Tradit. Chin. Med. 29: 795-796, 2013.
64. Wang, G., T.Q. Li, L. Wang, Q. Xia, J. Chang, Y. Zhang, M.H. Wan, J. Guo, Y. Cheng, X. Huang and R.M. Zhang. Tong-Xie-Ning, a Chinese herbal formula, in treatment of diarrheapredominant irritable bowel syndrome: A prospective, randomized, double-blind, placebocontrolled trial. Chin. Med. J. (Engl) 119: 2114-2119, 2006a.
65. Wang, G., T.Q. Li, L. Wang, Q. Xia, Y. Chen and R.M. Zhang. Tongxiening Granule in the treatment of diarrhea-predominant irritable bowel syndrome: A prospective, randomized placecontrolled, double-blind clinical trial. Chin. J. Evid. Based Med. 6: 84-89, 2006b.
66. Wang, H.Y., J.J. Shi and X.W. Li. Study on interference effect of Ningchang decoction on hypothalamus-pitutary-adrenal gland axis of rat with irritable bowel syndrome. Chin. J. Tradit. Med. Sci. Technol. 13: 393-394, 2006c.
67. Wang, X.Q. and W. Ye. Effect of Chaihu guizhi ganjiang decoction on gut hormone in the patients with diarrhea-predominant irritable bowel syndrome. Fujian J. Tradit. Chin. Med. 37: 10-11, 2006.
68. Wu, M.Y., T.M. Hu and X.S. Zheng. Huangshu enema downregulates VIP expression in the colonic mucosa of rats with diarrhea-predominant irritable bowel syndrome. W. Chin. J. Digestol. 18: 2966-2970, 2010.
69. Xie, J.Q., X. Lu, L.P. Gong, H.Y. Hu, G.T. Ma, J. Ma and X.X. Pan. Influence of spleen-nourishing and middle-warming therapy on vasoactive intestinal polypeptide in rats with irritable bowel syndrome of spleen-stomach deficiency-cold. Acta Univ. Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 17: 49-51, 2003.
70. Xie, J.Q. and J.Y. Yuan. Treatment of irritable bowel syndrome by Chinese medicine: Mechanisms of action. World Chin. J. Digestol. 18: 2230-2233, 2010.
71. Xu, H.Z., J.Q. Xie, B. Shi and T. Zhang. The Effects of Wenzhongjianpi decoction on the mast cell in the colon mucosa of rats with diarrhea irritable bowel syndrome. J. Jiangxi Univ. Tradit. Chin. Med. 19: 58-60, 2007.
72. Xu, H.Z., J.Q. Xie, D.Z. Wu and X. Lu. Effects of "Wenzhong Jianpi decoction" on 5-HT expressions in hypothalamus and colon mucosa in diarrhea-predominant irritable bowel syndrome rats. Acta Univ. Tradit. Med. Sin. Pharmacol. Shanghai 23: 29-32, 2009.
73. Xu, S., L.J. Jin, T. Tan, Y.M. Zhang and F.M. Chen. The effects of Lei-Wei-Yin on gastrointestinal hormones and oxygen free radicals in IBS rabbits of spleen deficiency. J. Zhejiang Univ. Tradit. Chin. Med. 32: 590-594, 2008.
74. Yang, J.S., S. Xu and J.J. Shi. Experimental research on treating irritable bowel syndrome with bowel-stabilizing decoction. J. Zhejiang Coll. Tradit. Chin. Med. 28: 48-53, 2004.
75. Yu, Y.Q. and F.J. Guo. The experimental study on gastrointestinal regulation effects of invigorating the spleen and dispersing the stagnated live-energy decoction. Tradit. Chin. Med. Res. 10: 16-18, 1997.
76. Zhang, J.Y., G.W. Chu, J. Nie and Y.F. Yang. Effects of Tongxieyaofang on the rats models with IBS induced by foot shock after inpouring acetic acid. Chin. J. Integr. Tradit. West. Med. Digestion 16: 221-223, 2008.
77. Zhang, S.S., H.B. Wang and Z.H. Li. A multi-center randomized controlled trial on treatment of diarrhea-predominant irritable bowel syndrome by Chinese medicine syndrome-differentiation therapy. Chin. J. Integr. Tradit. West. Med. 30: 9-12, 2010.
78. Zhao, S.M. and H.Z. Li. The action mechanisms of Tong-xie-yao-fang on irritable bowel syndrome. Hebei J. Tradit. Chin. Med. 34: 1736-1737, 2012.
79. Zhou, F.S. and H.H. Cheng. Treatment of irritable bowel syndrome by Chinese medicine: Theoretical research and clinical experience. World Chin. J. Digestol. 18: 2225-2229, 2010.
80. Zhu, Y.P., S.N. Lin, S. Huang and Z.Q. Luo. Clinical effect of No. 1 Shuiliao decoction in treatment of diarrhea-predominant irritable bowel syndrome (Damp-Heat Type) and its influence on plasma nitric oxide and endothelin. J. Guangxi Tradit. Chin. Med. Univ. 10: 10-12, 2007.